AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,050.00p
   
  • Change Today:
    -106.00p
  • 52 Week High: 12,178.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.24m
  • Volume: 1,635,158
  • Market Cap: £186,803m
  • RiskGrade: 123

Income Statement - Unadjusted

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 45,811.00 44,351.00 37,417.00 26,617.00 24,384.00
           
EBITDA 13,580.00 9,237.00 6,536.00 8,463.00 1,548.00
Depreciation & Amortisation (5,387.00) (5,480.00) (5,480.00) (3,301.00) n/a
           
Operating Profit/(Loss) 8,193.00 3,757.00 1,056.00 5,162.00 1,548.00
Interest Payable (1,626.00) (1,346.00) (1,300.00) (1,306.00) n/a
Interest Receivable/Investment Income 344.00 95.00 43.00 87.00 n/a
           
Group Profit after Interest 6,911.00 2,506.00 (201.00) 3,943.00 1,548.00
Share of Assoc Cos/JV Profits (12.00) (5.00) (64.00) (27.00) n/a
           
Profit Before Tax 6,899.00 2,501.00 (265.00) 3,916.00 1,548.00
Tax (938.00) 792.00 380.00 (772.00) (321.00)
           
Profit After Tax 5,961.00 3,293.00 115.00 3,144.00 1,227.00
           
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
           
PROFIT FOR THE PERIOD 5,961.00 3,293.00 115.00 3,144.00 1,227.00
           
Attributable to:          
Equity Shareholders' Earnings 5,955.00 3,288.00 112.00 3,196.00 1,335.00
Minority interests 6.00 5.00 3.00 (52.00) (108.00)
           
Equity Dividends cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year cn/a cn/a cn/a cn/a cn/a


Per Share Record - Unadjusted 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing EPS          
Earnings per Share - Basic 384.00¢ 212.00¢ 8.00¢ 244.00¢ 103.00¢
Earnings per Share - Diluted 381.00¢ 211.00¢ 8.00¢ 244.00¢ 103.00¢
Continuing and Discontinued EPS          
Earnings per Share - Basic 384.00¢ 212.00¢ 8.00¢ 244.00¢ 103.00¢
Earnings per Share - Diluted 381.00¢ 211.00¢ 8.00¢ 244.00¢ 103.00¢
           
Dividend per Share 290.00¢ 290.00¢ 287.00¢ 280.00¢ 280.00¢


Key Financals 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Shares in Issue (millions)          
Shares in Issue - Year End 1,550.16 1,549.80 1,549.40 1,312.67 1,312.14
Weighted Average 1,549.00 1,548.00 1,418.00 1,312.00 1,301.00
Diluted 1,562.00 1,560.00 1,427.00 1,313.00 1,301.00
           
Performance Ratios          
Continuing Operations          
Operating Margin 17.88% 8.47% 2.82% 19.39% 6.35%
Tax Rate 13.57% (31.60%) 189.05% 19.58% 20.74%
Return on Capital Employed 60.06% 34.10% 0.07% 76.32% 76.87%
Continuing Operations & Discontinued Operations          
Return on Equity (ROE) 13.81% 8.04% n/a 16.71% 8.11%
           
Financial Status          
Continuing Operations          
Interest Cover 5.24 2.86 0.80 4.00 n/a
Revenue per Share 2,957.46¢ 2,865.05¢ 26.64¢ 2,028.73¢ 1,874.25¢
Pre-Tax Profit per Share 445.38¢ 161.56¢ (0.19¢) 298.48¢ 118.98¢
           
Market Data          
Continuing Operations          
Earnings per Share Growth - Basic 81% 2,550% -97% 137% -39%
Earnings per Share Growth - Adjusted 81% 2,550% -97% 137% -39%
Earnings per Share Growth - Diluted 81% 2,538% -97% 137% -39%
PE Ratio - Adjusted 34.6 66.4 1,361.0 37.7 92.7
PEG - Adjusted 0.4 0.0 n/a 0.3 n/a
Dividend Cover 1.32 0.73 0.03 0.87 0.37
Continuing Operations & Discontinued Operations          
Earnings per Share Growth - Basic 81% 262,432% -100% 137% 21%
Earnings per Share Growth - Adjusted 81% 262,432% -100% 137% 21%
Earnings per Share Growth - Diluted 81% 261,193% -100% 137% 21%
PE Ratio - Adjusted 34.6 66.4 134,833.6 37.7 92.7
PEG - Adjusted 0.4 0.0 n/a 0.3 4.4
Dividend Cover 1.32 0.73 n/a 0.87 0.37
           
Market Capitalisation $ (Millions) 164,317.24 173,856.57 134,456.99 96,139.85 99,814.33
Dividend per Share 290.00¢ 290.00¢ 287.00¢ 280.00¢ 280.00¢
Dividend Yield 2.2% 2.1% 2.6% 3.0% 2.9%
Dividend per Share Growth n/a 1.05% 2.50% n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page